Assignee
AIVITA BIOMEDICAL INC
US·2 granted patents·8 pending applications·1 citations·filing 2017–2025
Top patents by PatentIndex Score
10 records- 0178US12268770B2Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2023·Granted Apr 8, 2025·0 cites·17 claims
- 0278US11666522B2Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2018·Granted Jun 6, 2023·1 cites·24 claims
- 0374US2025288512A1Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2024·Application pending·0 cites
- 0470US2025236841A1Methods to enhance tumor immunogenicity and compositions for autologous cancer immunotherapeutic products using modified tumor cells and modified dendritic cellsAIVITA BIOMEDICAL INC·Filed 2024·Application pending·0 cites
- 0564US2025387314A1Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2025·Application pending·0 cites
- 0663US2022347277A1Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic CellsAIVITA BIOMEDICAL INC·Filed 2022·Application pending·0 cites
- 0760US2019358145A1Use of cell membrane-bound signaling factorsAIVITA BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 0857US2023210982A1Autologous dendritic cell vaccine kit and usesAIVITA BIOMEDICAL INC·Filed 2022·Application pending·0 cites
- 0952US2020230219A1Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic CellsAIVITA BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1046US2022268775A1Soluble programmed cell death protein-1 as a biomarker in cancer patientsAIVITA BIOMEDICAL INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AIVITA BIOMEDICAL INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →